Literature DB >> 15664254

Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels.

Alfredo Alberti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15664254     DOI： 10.1016/j.jhep.2004.12.004

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  7 in total

1.  Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase.

Authors:  R Moreno-Otero; M Trapero-Marugan; J Mendoza
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

2.  Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C.

Authors:  Yumi Kobayashi; Yasunori Kawaguchi; Toshihiko Mizuta; Takuya Kuwashiro; Satoshi Oeda; Noriko Oza; Hirokazu Takahashi; Shinji Iwane; Yuichiro Eguchi; Keizo Anzai; Iwata Ozaki; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2010-11-03       Impact factor: 7.527

Review 3.  In the clinic. Hepatitis C.

Authors:  Janice H Jou; Andrew J Muir
Journal:  Ann Intern Med       Date:  2008-06-03       Impact factor: 25.391

Review 4.  Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.

Authors:  Giada Sebastiani; Alfredo Alberti
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

5.  Analysis of hepatitis C virus hypervariable region 1 sequence from cryoglobulinemic patients and associated controls.

Authors:  Gabriella Bianchettin; Claudia Bonaccini; Romina Oliva; Anna Tramontano; Agostino Cividini; Milvia Casato; Giampaolo Merlini; Enrico Silini; Mario U Mondelli
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

6.  Alanine aminotransferase flare-up in hepatitis C virus carriers with persistently normal alanine aminotransferase levels in a hyperendemic area of Japan.

Authors:  Hirofumi Uto; Joji Kurogi; Yuka Takahama; Kazunori Kusumoto; Katsuhiro Hayashi; Akio Ido; Michinori Kohara; Sherri O Stuver; Akihiro Moriuchi; Susumu Hasegawa; Makoto Oketani; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

7.  APASL consensus statements and management algorithms for hepatitis C virus infection.

Authors:  Masao Omata; Tatsuo Kanda; Ming-Lung Yu; Osamu Yokosuka; Seng-Gee Lim; Wasim Jafri; Ryosuke Tateishi; Saeed S Hamid; Wan-Long Chuang; Anuchit Chutaputti; Lai Wei; Jose Sollano; Shiv Kumar Sarin; Jia-Horng Kao; Geoffrey W McCaughan
Journal:  Hepatol Int       Date:  2012-03-01       Impact factor: 9.029
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.